Insulet (PODD) Asset Writedowns and Impairment (2016 - 2026)
Insulet filings provide 16 years of Asset Writedowns and Impairment readings, the most recent being $100000.0 for Q3 2025.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A to $100000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.3 million, a 437.5% increase, with the full-year FY2024 number at -$200000.0, down 108.7% from a year prior.
- Asset Writedowns and Impairment hit $100000.0 in Q3 2025 for Insulet, down from $300000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.8 million in Q1 2025 to a low of -$900000.0 in Q4 2024.
- Median Asset Writedowns and Impairment over the past 5 years was $750000.0 (2021), compared with a mean of $805555.6.
- Biggest five-year swings in Asset Writedowns and Impairment: surged 450.0% in 2022 and later crashed 550.0% in 2024.
- Insulet's Asset Writedowns and Impairment stood at $300000.0 in 2021, then skyrocketed by 266.67% to $1.1 million in 2022, then plummeted by 81.82% to $200000.0 in 2023, then crashed by 550.0% to -$900000.0 in 2024, then soared by 111.11% to $100000.0 in 2025.
- The last three reported values for Asset Writedowns and Impairment were $100000.0 (Q3 2025), $300000.0 (Q2 2025), and $4.8 million (Q1 2025) per Business Quant data.